"id","uuid:ID","description","instanceType","name","label","text"
"Objective_1","33ceaba9-5242-4959-9e1f-8d8a669ab34a","Main objective","Objective","OBJ1","","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg])."
"Objective_2","d6af1289-75f9-4933-81bc-9538b10c6564","Safety","Objective","OBJ2","","To document the safety profile of the xanomeline TTS."
"Objective_3","27d20a41-fa19-4418-a5aa-63941db2304d","Behaviour","Objective","OBJ3","","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas."
